The latter approach is reaching maturity in excellent new studies in which patient-derived xenotransplanted human T-ALL cells are killed with a chimeric monoclonal antibody against human IL-7Rα/CD127 in vivo via antibody-dependent cell-mediated cytotoxicity (55). Here, IL7R is linked to acute lymphoblastic leukemia.